Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This approach aims to improve treatment precision and patient quality of life
Use it in the morning under sunscreen or at night after treatments
Store GHK-Cu after reconstitution at 28C (refrigerated) in a sterile, sealed vial away from light
Dimet-Wiley A, et al
2021 Mar 18;384(11):9891002
This includes individuals with: Diagnosed MASLD or MASH, where GLP-1 therapy may offer therapeutic benefits but requires monitoring Chronic viral hepatitis (hepatitis B or C), particularly if transaminases are elevated Autoimmune hepatitis or other inflammatory liver conditions Cirrhosis or advanced fibrosis, where specialist consultation may be appropriate despite generally not requiring dose adjustment History of drug-induced liver injury from other agents For these patients, baseline comprehensive liver assessmentincluding liver enzymes, synthetic function tests (albumin, INR), and potentially imaging or non-invasive fibrosis markers (such as FIB-4 or ELF)helps establish a reference point for monitoring treatment effects
US$ 24.91
US$ 26.47
US$ 25.97
US$ 23.35
US$ 21.48
US$ 22.61
US$ 21.63
US$ 27.83
US$ 23.93
US$ 22.25
US$ 23.26
